KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Current Leases (2016 - 2018)

Gsk (GSK) has 3 years of Current Leases data on record, last reported at $308.6 million in Q4 2019.

  • For Q4 2019, Current Leases rose 899.19% year-over-year to $308.6 million; the TTM value through Dec 2019 reached $308.6 million, up 899.19%, while the annual FY2019 figure was $306.4 million, 856.03% up from the prior year.
  • Current Leases reached $308.6 million in Q4 2019 per GSK's latest filing, up from $30.9 million in the prior quarter.
  • Across five years, Current Leases topped out at $308.6 million in Q4 2019 and bottomed at $30.5 million in Q4 2017.
  • Average Current Leases over 3 years is $123.3 million, with a median of $30.9 million recorded in 2018.
  • Peak YoY movement for Current Leases: grew 1.13% in 2018, then skyrocketed 899.19% in 2019.
  • A 3-year view of Current Leases shows it stood at $30.5 million in 2017, then grew by 1.13% to $30.9 million in 2018, then surged by 899.19% to $308.6 million in 2019.
  • Per Business Quant database, its latest 3 readings for Current Leases were $308.6 million in Q4 2019, $30.9 million in Q4 2018, and $30.5 million in Q4 2017.